Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.71 -0.04 (-5.12%)
As of: Oct 20, 2026 · 9:33 AM EDT

Scinai Immunotherapeutics (SCNI) Gross Profit (2024 - 2026)

Updated

Scinai Immunotherapeutics (SCNI) posted Gross Profit of -$1.25 million for Q2 2026, compared with -$1.5 million a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Gross Profit (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Scinai Immunotherapeutics was -$3.64 million; for FY2025, it was -$4.33 million.

  • In prior years, Scinai Immunotherapeutics' Gross Profit was -$580,000 in FY2024.
  • Quarterly Gross Profit has run from a low of -$1.5 million in Q2 2025 to a high of $228,000 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,143.87 Bn 1,112.46 Bn 19.71 Bn
2 Johnson & Johnson 621.90 Bn 540.43 Bn 17.26 Bn
3 AbbVie 507.81 Bn 480.92 Bn 12.70 Bn
4 Merck 364.52 Bn 318.90 Bn 12.21 Bn
5 Novartis Ag 295.78 Bn 259.77 Bn 11.24 Bn
6 Astrazeneca 259.85 Bn 233.54 Bn 12.86 Bn
7 Amgen 231.44 Bn 186.84 Bn 7.24 Bn
8 Gilead Sciences 193.87 Bn 168.07 Bn 6.22 Bn
9 Pfizer 170.66 Bn 117.30 Bn 10.94 Bn
10 Scinai Immunotherapeutics 165,775.43 -8.10 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.25 Mn
Mar 31, 2026 -1.12 Mn
Jun 30, 2025 -1.50 Mn
Mar 31, 2025 228,000.00
Dec 31, 2024 -167,000.00
Sep 30, 2024 -249,000.00
API Access

Scinai Immunotherapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=SCNI&period=max&api_key=YOUR_API_KEY